PMID- 18474676 OWN - NLM STAT- MEDLINE DCOM- 20080926 LR - 20121115 IS - 1521-009X (Electronic) IS - 0090-9556 (Linking) VI - 36 IP - 8 DP - 2008 Aug TI - UDP-glucuronosyltransferase 1A6 is the major isozyme responsible for protocatechuic aldehyde glucuronidation in human liver microsomes. PG - 1562-9 LID - 10.1124/dmd.108.020560 [doi] AB - Glucuronidation is an important pathway in the metabolism of protocatechuic aldehyde (3,4-dihydroxybenzaldehyde, PAL). However, the metabolites and primary UDP-glucuronosyltransferase (UGT) isozymes responsible for PAL glucuronidation remain to be determined in human. Here, we characterized PAL glucuronidation by human liver microsomes (HLMs), human intestine microsomes (HIMs), and 12 recombinant UGT (rUGT) isozymes to identify what kinds of metabolites are present and which human UGT isozymes are involved. Two metabolites (M-1 and M-2) were detected in reactions catalyzed by HLMs, HIMs, rUGT1A6, and rUGT1A9 and were identified as monoglucuronides by liquid chromatography-mass spectrometry. A kinetic study showed that PAL glucuronidation by rUGT1A6, rUGT1A9, HIMs, and HLMs followed Michaelis-Menten kinetics. The K(m) values of HLMs, HIMs, rUGT1A6, and rUGT1A9 for PAL glucuronidation were as follows: 432.7 +/- 24.5, 626.9 +/- 49.2, 367.5 +/- 25.1, and 379.9 +/- 42.5 microM for M-1 and 336.7 +/- 15.3, 494.3 +/- 48.7, 211.4 +/- 13.4, and 238.5 +/- 26.2 microM for M-2, respectively. The PAL glucuronidation activity was significantly correlated with UGT1A6 activity rather than with UGT1A9 activity from 15 individual HLMs. A chemical inhibition study showed that the IC(50) for phenylbutazone inhibition of PAL glucuronidation was similar in HLMs (61.9 +/- 7.9 microM) compared with rUGT1A6 (45.3 +/- 7.7 microM). In contrast, androsterone inhibited rUGT1A9-catalyzed and HLM-catalyzed PAL glucuronidation with IC(50) values of 27.1 +/- 3.8 and > 500 microM, respectively. In combination, we identified UGT1A6 as the major isozyme responsible for PAL glucuronidation in HLMs. FAU - Liu, Hui-Xin AU - Liu HX AD - Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, No. 457 Zhongshan Rd., Dalian 116023 China. FAU - Liu, Yong AU - Liu Y FAU - Zhang, Jiang-Wei AU - Zhang JW FAU - Li, Wei AU - Li W FAU - Liu, Hong-Tao AU - Liu HT FAU - Yang, Ling AU - Yang L LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080512 PL - United States TA - Drug Metab Dispos JT - Drug metabolism and disposition: the biological fate of chemicals JID - 9421550 RN - 0 (Benzaldehydes) RN - 0 (Catechols) RN - 0 (Glucuronides) RN - 0 (Isoenzymes) RN - 4PVP2HCH4T (protocatechualdehyde) RN - EC 2.4.1.17 (Glucuronosyltransferase) SB - IM MH - Benzaldehydes/*pharmacokinetics MH - Biotransformation MH - Catechols/*pharmacokinetics MH - Chromatography, High Pressure Liquid MH - Glucuronides/*metabolism MH - Glucuronosyltransferase/*metabolism MH - Humans MH - Isoenzymes/*metabolism MH - Microsomes, Liver/*enzymology/metabolism MH - Spectrophotometry, Ultraviolet EDAT- 2008/05/14 09:00 MHDA- 2008/09/27 09:00 CRDT- 2008/05/14 09:00 PHST- 2008/05/14 09:00 [pubmed] PHST- 2008/09/27 09:00 [medline] PHST- 2008/05/14 09:00 [entrez] AID - dmd.108.020560 [pii] AID - 10.1124/dmd.108.020560 [doi] PST - ppublish SO - Drug Metab Dispos. 2008 Aug;36(8):1562-9. doi: 10.1124/dmd.108.020560. Epub 2008 May 12.